Geriatric Assessment in patients older than 60 years with hematological malignancies undergoing allogeneic stem cell transplantation

Geriatric Assessment in patients older than 60 years with hematological malignancies undergoing allogeneic stem cell transplantation - none

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003694

Enrollment

110

Registered

2012-04-30

Start date

2010-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C92.0 D46

Interventions

Group 1: There is no intervenention. The Geriatric Assessment takes about 45 minutes and consists of a number of validated tests and questionnaires. It will be performed on day 0, 30, and 90.

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: written informed consent, higher risk MDS, AML, anticipated allogeneic stem cell transplantation, mental capacity top fill out questionnaires and obey simple orders. Regional proxicity for regular follow-up

Exclusion criteria

Exclusion criteria: other malignancies not in remission, inability to fill out german questionnaires, lack of informed consent. Trial participation in a medical treatment study is NOT an exclusion criterion.

Design outcomes

Primary

Measure	Time frame
Progression free survival (PFS). Hazard ratios for PFS will be calculated	—

Secondary

Measure	Time frame
Overall survival	—

Countries

Germany

Contacts

Public ContactBarbara Deschler

Medizinische Unviversitätklinik Freiburg

barbara.deschler@uniklinik-freiburg.de0761-279-33110

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026